Edwards Lifesciences (EW) Return on Capital Employed (2010 - 2026)
Edwards Lifesciences (EW) posted quarterly Return on Capital Employed of 11.13% for Q1 2026, down 110.0% year-over-year from 111.32% in Q1 2025, and up 2.77% quarter-over-quarter from 10.83% in Q4 2025.
Edwards Lifesciences (EW) Return on Capital Employed (2010 - 2026) Analysis & Trends
Edwards Lifesciences' Return on Capital Employed history runs 17 years deep, the most recent figure standing at 11.13% for Q1 2026.
- In Q1 2026, Return on Capital Employed fell 110.0% year-over-year to 11.13%; the TTM figure through Mar 2026 stood at 11.13% (down 110.0% YoY), while the FY2025 annual figure was 10.93%, down 327.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 11.13%, up from 10.83% in the prior quarter.
- The five-year high for Return on Capital Employed was 23.24% in Q1 2022, with the low at 10.83% in Q4 2025.
- The 5-year median for Return on Capital Employed is 15.7% (2024), against an average of 16.07%.
- The sharpest annual moves came in 2022 and 2023: Return on Capital Employed jumped 888 bps in 2022, then tumbled 671 bps in 2023.
- Edwards Lifesciences' Return on Capital Employed stood at 20.13% in 2022, then dropped by 17 bps to 16.7% in 2023, then slipped by 28 bps to 11.98% in 2024, then slipped by 10 bps to 10.83% in 2025, then gained by 3 bps to 11.13% in 2026.
- Business Quant data shows EW's Return on Capital Employed at 11.13% in Q1 2026, 10.83% in Q4 2025, and 12.09% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 7.98% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 13.69% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 10.83% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 11.99% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 27.21% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 9.47% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 12.84% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 12.08% |
| 10 | Zimmer Biomet Holdings | 19.04 Bn | 18.63 Bn | 1.54 Bn | 6.10% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.99% |
| Mar 31, 2026 | 11.13% |
| Dec 31, 2025 | 10.83% |
| Sep 30, 2025 | 12.09% |
| Jun 30, 2025 | 12.40% |
| Mar 31, 2025 | 12.23% |
| Dec 31, 2024 | 11.98% |
| Sep 30, 2024 | 14.73% |
| Jun 30, 2024 | 16.41% |
| Mar 31, 2024 | 15.70% |
| Dec 31, 2023 | 16.70% |
| Sep 30, 2023 | 15.29% |
| Jun 30, 2023 | 16.32% |
| Mar 31, 2023 | 19.59% |
| Dec 31, 2022 | 20.13% |
| Sep 30, 2022 | 22.00% |
| Jun 30, 2022 | 22.31% |
| Mar 31, 2022 | 23.24% |
| Dec 31, 2021 | 23.16% |
| Sep 30, 2021 | 24.01% |